Wednesday, July 14, 2021

Investor Ideas #Potcasts 587, #Cannabis News and #Stocks on the Move- Interview with CEO of Silo Wellness Inc. (CSE: $SILO.C) (OTCQB: $SILFF)


Investor Ideas #Potcasts 587, #Cannabis News and #Stocks on the Move- Interview with CEO of Silo Wellness Inc. (CSE: $SILO.C) (OTCQB: $SILFF)


Delta, Kelowna, BC, July 14, 2021 ( Newswire) www.Investoride,, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.


Listen to the podcast:


read this in full at


Hear Investor ideas cannabis potcast on iTunes


Hear the investor ideas potcast on Spotify


Today’s podcast overview/transcript:


Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.


In today’s podcast Investorideas interviews Douglas K. Gordon, CEO of Silo Wellness Inc. (CSE: SILO) (OTCQB:SILFF), a leading global psychedelics company, where we discussed the company’s recent partnership with the Bob Marley Group Of Companies, navigating the functional and psychedelic mushroom landscape as well as the company’s psychedelic retreats in Oregon and Jamaica.


Founded in 2018, Silo Wellness is a ‘spore-to-door’ vertically integrated company and the leading psilocybin cultivator and facilitator of psychedelic retreats in Jamaica, a jurisdiction where the cultivation, extraction, and consumption of psilocybin mushrooms is permissible. In 2019, the Company announced proof of concept of a patent-pending psilocybin nasal spray. In addition to its market-leading mushroom and psilocybin products, Silo Wellness conducts ketamine-assisted retreats in Oregon and recently expanded its psychedelic offerings to introduce 5-MeO-DMT-enhanced retreats across Jamaica.



The company recently announced the launch of Marley One, the first global functional and psychedelic mushroom consumer brand, in collaboration with the family of legendary musician Bob Marley. The initial product offering will include a range of functional mushroom tinctures with unique blends highlighting the brand’s connection to Jamaica, including species such as cordyceps, lion's mane, chaga, reishi and turkey tail that offer a range of unique health and wellness benefits, from immunity and gut health to cognitive function and sleep enhancement. The Company intends to launch a psychedelic mushroom product line under the Marley name later this year, to be followed by additional functional mushroom products including gummies, capsules and cosmetics.


When asked about this partnership and its importance to the company, Douglas Gordon commented, “Bob Marley has represented the idea of us all being one, in the spirit of what he sang about, what he espoused and what he spoke to. In many ways it's been about people, we are all one people and I think what  we’ve learned through understanding plant medicine better, and mushrooms specifically, is that we are really one Earth and the Earth can’t heal itself. Why I say all this is in relation to the Bob Marley relationship is because having any association with a figure like that, and a whole mantra and way of being that Bob Marley represents, for us is such a connected part of who we are as an organization. We believe very strongly, not just in the tremendous benefits that psychedelics can offer us in terms of the future of understanding mental health, but it also allows us to do something very germaine to who we are. We operate in Jamaica and we respect the indigenous cultures that for many hundreds of years have spoken to the use of psychedelics, and so it’s a wonderful place to be where we can marry modern medicine today with these long standing traditions. For us to be able to speak to the rastafarian culture and incorporate that into what we are doing is something we are very proud of and is also very resonant.”


The Marley One product line currently includes:

       One Mind: A coffee-flavored blend of lion’s mane and L-theanine designed to improve focus and cognitive function.

       One Flow: A peppermint-flavored blend of cordyceps and ginseng designed to enhance physical endurance and mental function.

       One Harmony: A mango-flavored blend of chaga and ginger designed to stimulate gut health and improve digestion.

       One Body: A berry-flavored blend of turkey tail and astragalus designed to support immune health.

       One Rest: A vanilla-flavored blend of reishi and GABA designed to help reduce tension and stress and improve quality of sleep.


Gordon continued, saying “From the business perspective it allows us to educate people about functional mushrooms in the first instance. It allows us to go to folks who are familiar and trust the Bob Marley brand and make them more comfortable to understand and be curious about what this can do for me? In the process what we believe will happen is not only will more people come to understand the power and health benefits of functional mushrooms , but they will also open up their minds and be more curious and willing to learn about psychedelics. That’s where we think the greatest power is. Functional mushrooms are fantastic from a health and wellness “superfood” type of perspective and so we are happy to be in that space, but we are also happy, having seen how CBD and Cannabis evolved previously, that this gives us a pathway to having more people open their minds to mushrooms and psychedelics in general, and that’s where the real healing begins.”


Cedella Marley, CEO of Bob Marley Group of Companies, commented in the company’s recent press release, saying “As a family, we seek to use our platform to inspire positive change, and the launch of the Marley One mushroom brand, in collaboration with a pioneering company like Silo Wellness, allows us to do just that by marrying ancient wisdom with modern science. It’s our wish that these products will empower people to experience oneness with nature and the universe at large - and ultimately, achieve greater self-actualization.”

Gordon went on to discuss the company’s psychedelic retreats in both Jamaica and Oregon saying, “We are in the early stage at this part of the business as we started our retreats in January in both Jamaica and Oregon. What we brought into our retreats is very much what the foundation of it is, and we built it around the basis of being very respectful to the history of the mushroom and the history of the experience. We want to make indigenous cultures a very core part of what we offer. The ways to have a proper psychedelic retreat and experience start with set, setting and integration. We put a lot of emphasis on getting the set, setting and integration right, but it's so important that you get folks attached to it that understand that the powerful tool here is the medicine, not the driver of the bus, not the shaman or retreat leader. We spent a lot of time ensuring that the people we have attached to what we are doing, that that’s their philosophy. It’s really about being guides for the medicine and telling people and telling folks that it's you healing yourself and it's your mind reinterpreting these traumas for yourself. It’s also important for us that we give people memorable experiences. We take you out into nature, we have yoga, we have sound healing and we keep looking to see which particular elements work well together. We keep getting the question from the investment community asking, how is this scalable? The truth is you have numbers at which point the experience between the individuals starts to break down. So how we do it is we limit the number, we limit it to 10-15 people max, and we also do individual and curated and themed retreats.”


Douglas K. Gordon went on to discuss some of the different themed retreats they are currently working with as well as the future potential of these retreats, not just in medicinal uses, but also in the world of business, science and creative thinking.


Gordon also discussed the company’s data research partnership with Ehave, Inc. (OTC: EHVVF), the different demographics of some of their early retreats, the potential for psychedelics in the future as well as the many business opportunities within the functional mushrooms segment and how this leads into psychedelics.


To find out more about Silo Wellness Inc. visit their website here.


For more information or to purchase Marley One products online, please visit


Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.


Learn more about our cannabis podcasts at


To hear more podcasts visit:

The podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher,, iHeartRadio ,  Google Play Music and most audio platforms available.


Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:


Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at


Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android 

Join our Investor Club



800 665 0411



  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


No comments:

Post a Comment